Neurochemical phenotype of relaxin family peptide receptor-3 (RXFP3) lateral hypothalamus/zona incerta cells

This study utilizes RNAscope fluorescent in situ hybridization to map the rostrocaudal distribution and neurochemical diversity of RXFP3-expressing neurons in the mouse lateral hypothalamus and zona incerta, revealing their co-expression with markers for GABAergic, glutamatergic, and dopaminergic populations involved in stress, arousal, and defensive behaviors.

The Gist

Imagine your brain is a massive, bustling city. In this city, there are two very important neighborhoods: the Lateral Hypothalamus (LH) and the Zona Incerta (ZI).

For a long time, scientists thought of these neighborhoods as having specific jobs. The LH was like the "Hunger and Sleep Station," while the ZI was a mysterious, long strip of land that seemed to act as a bridge between different parts of the brain. But recently, researchers discovered a special group of cells in these neighborhoods that act like security guards for your brain's "fight or flight" system. These guards are equipped with a specific radio receiver called RXFP3.

This new study is like a detailed census of those security guards. The researchers wanted to answer a simple question: Who are these guards, and what kind of personalities do they have?

The Big Discovery: A Diverse Team, Not a Clone Army

In the past, scientists might have assumed that all security guards in a specific building looked the same and wore the same uniform. But this study found that the RXFP3 guards are incredibly diverse. They aren't a clone army; they are a mixed bag of different specialists.

Here is how the researchers broke it down using simple analogies:

1. The "Radio Receiver" (RXFP3)
Think of RXFP3 as a walkie-talkie. The brain sends out a specific message (a chemical called relaxin-3) that says, "Alert! Something scary is happening!" The cells with RXFP3 are the ones that can hear this message. The study found that these walkie-talkies are everywhere in the LH and ZI neighborhoods, but they are most common in the front (rostral) parts of these areas.

2. The Uniforms (Neurochemical Markers)
To figure out what these guards actually do, the researchers looked at their "uniforms." In the brain, these uniforms are chemicals that tell you what the cell's job is:

• GABA (The Brake Pedal): These cells slow things down.
• Glutamate (The Gas Pedal): These cells speed things up.
• Dopamine (The Reward/Movement Signal): These cells are involved in motivation and movement.
• Parvalbumin & Somatostatin: These are like specialized badges indicating specific roles in fear and anxiety.

What they found:
The RXFP3 guards weren't just wearing one type of uniform.

• In the ZI neighborhood, most of the guards were wearing "Brake Pedal" (GABA) uniforms, but a few were wearing "Gas Pedal" (Glutamate) uniforms.
• In the LH neighborhood, it was a 50/50 split. Some were "Gas Pedal" guards, and some were "Brake Pedal" guards.
• Some guards even had dual badges (like being both a Dopamine expert and a Parvalbumin expert), which is rare and exciting.

Why Does This Matter?

Think of the LH and ZI as the Brain's "High-Vigilance Control Center." When you are walking alone at night and hear a twig snap, this control center wakes up. It decides: Do I freeze? Do I run? Do I fight?

The study suggests that the RXFP3 system is like a master switch that can tune the entire control center. Because these RXFP3 cells are so diverse (some are gas pedals, some are brakes, some are movement experts), the relaxin-3 signal can do many different things at once. It can tell the brain to:

• Freeze in fear.
• Jump to escape.
• Become hyper-aware of your surroundings.

The "Swiss Army Knife" Analogy

Imagine the RXFP3 system as a Swiss Army Knife.

• If you only had a screwdriver (one type of cell), you could only fix screws.
• But because the RXFP3 system has a blade, a screwdriver, a can opener, and a corkscrew all in one (GABA, Glutamate, Dopamine, etc.), it can handle any emergency situation the brain faces.

The researchers found that the mix of tools in the knife changes depending on where you are in the city (the specific part of the LH or ZI).

• In the front of the city, the guards are mostly "Brake Pedal" types (GABA).
• In the back of the city, you find more "Gas Pedal" types (Glutamate) and "Movement" types (Dopamine).

The Takeaway

This paper tells us that the brain's fear and stress system is much more complex and flexible than we thought. The cells that listen to the "Relaxin-3" alarm aren't just one type of worker; they are a special forces team made up of different specialists.

This is great news for understanding diseases like anxiety, PTSD, or stress disorders. If we want to fix a broken alarm system, we can't just treat the whole building the same way. We need to know exactly which "uniform" (cell type) is malfunctioning in which part of the city. By mapping out these different types of RXFP3 cells, scientists are one step closer to creating targeted treatments that can calm the brain's alarm system without turning off the lights entirely.

Technical Summary

1. Problem Statement

The relaxin-3/relaxin family peptide receptor 3 (RXFP3) neuropeptidergic system is a potential therapeutic target for neuropsychiatric disorders involving stress and arousal dysregulation. While RXFP3 is known to be densely expressed in the lateral hypothalamus (LH) and zona incerta (ZI), and recent studies suggest LH/ZI RXFP3+ cells regulate defensive behaviors, the specific neurochemical identity of these cells remains undefined.

• The Gap: Previous functional studies often treated these nuclei as homogeneous or relied on single-marker classifications (e.g., solely GABAergic or glutamatergic). However, the LH and ZI are highly heterogeneous. Without knowing the neurotransmitter phenotype (GABA, glutamate, dopamine, etc.) and co-expression patterns of RXFP3+ cells, it is impossible to fully understand their specific roles in fear learning, arousal, and defensive behaviors.
• Objective: To comprehensively map the spatial distribution and characterize the neurochemical phenotype of RXFP3-expressing cells across the rostrocaudal extent of the mouse LH and ZI.

2. Methodology

The study utilized RNAscope® fluorescent in situ hybridisation (FISH), a highly sensitive technique capable of detecting single mRNA molecules, to overcome limitations of previous antibody-based or lower-sensitivity in situ methods.

• Subjects: Inbred adult male RXFP3-Cre mice ($n=8$).
• Tissue Preparation: Brains were sectioned coronally (17 µm for fixed-frozen, 8 µm for fresh-frozen) across the rostrocaudal axis of the LH and ZI.
• Multiplexing Strategy: The study employed a multiplexed approach to co-detect Rxfp3 mRNA with markers for:
  • Neurotransmitters: Slc17a6 (vGlut2, glutamatergic) and Gad1 (GAD1, GABAergic).
  • Calcium-binding proteins/Enzymes: Pvalb (Parvalbumin), Th (Tyrosine Hydroxylase, dopaminergic), and Sst (Somatostatin).
• Quantification & Analysis:
  • Cells were manually outlined based on the Paxinos & Franklin Mouse Brain Atlas.
  • QuPath software was used for automated cell detection and classification. A semi-quantitative threshold (≥2 fluorescent dots within 5 µm of the nucleus) defined "positive" cells.
  • Statistical Modeling: Mixed-effects logistic regressions and multinomial/binomial logistic regressions were used to analyze the relationship between rostrocaudal position and neurochemical co-expression, accounting for inter-individual variability.

3. Key Results

A. Spatial Distribution of Rxfp3

• Prevalence: Rxfp3 mRNA is expressed in approximately 18% of ZI and 16% of LH DAPI+ cells.
• Pattern: Expression follows a parabolic (inverted U) distribution across the rostrocaudal axis in both nuclei, peaking in more rostral regions:
  • ZI Peak: ~-1.41 mm from Bregma (rostral part of the intermediate ZI).
  • LH Peak: ~-1.47 mm from Bregma (bordering intermediate and caudal anterior LH).
• Clustering: Dense clusters were observed in the medial ZI surrounding the mammillothalamic tract and in the caudal anterior LH surrounding the fornix.

B. Neurochemical Phenotyping

The study revealed that RXFP3+ cells are neurochemically diverse and generally co-express markers proportional to the overall abundance of those markers in the specific sub-region, rather than showing strict selectivity.

1. Glutamate vs. GABA (Experiment 1):

• ZI: Predominantly GABAergic. 82.1% of ZI RXFP3+ cells were Gad1+, while only 1.4% were Slc17a6+. However, a significant portion of Slc17a6+ cells in the ZI (34.6%) expressed Rxfp3.
• LH: More balanced. 26.4% of LH RXFP3+ cells were Gad1+ and 35.2% were Slc17a6+.
• Co-expression: A small but distinct population of triple-positive cells (Rxfp3+/Gad1+/Slc17a6+) was identified, particularly in the caudal anterior LH (8% of the population), suggesting potential glutamate/GABA co-release.

2. Dopamine (Th) and Parvalbumin (Pvalb) (Experiment 2):

• A13 Dopaminergic Group: In the rostromedial ZI, 55% of RXFP3+ cells were Th+ (dopaminergic), and 31.5% of A13 Th+ cells expressed Rxfp3.
• Parvalbumin: 45.3% of ZI RXFP3+ cells were Pvalb+. In the LH, 12.6% were Pvalb+.
• Distribution: Rxfp3+/Th+ cells were concentrated in the A13 group (rostral ZI), while Rxfp3+/Pvalb+ cells were ubiquitous but increased in density toward the caudal ZI.

3. Somatostatin (Sst) (Experiment 3):

• Overlap: Approximately 14-15% of RXFP3+ cells in both LH and ZI co-expressed Sst.
• Specificity: This represents a partial overlap; RXFP3 and SST populations are largely distinct but intersect significantly in the rostral ZI and intermediate anterior LH.

C. Rostrocaudal Heterogeneity

Statistical analysis confirmed that the neurochemical composition of RXFP3+ cells varies significantly along the rostrocaudal axis. For example, the proportion of GABAergic RXFP3+ cells was higher in the caudal ZI, while dopaminergic overlap was restricted to the rostral ZI (A13).

4. Key Contributions

1. High-Resolution Mapping: Provided the first comprehensive, high-sensitivity map of Rxfp3 mRNA distribution in the mouse LH and ZI, correcting previous underestimations found in lower-sensitivity studies (e.g., Allen Brain Atlas, Smith et al., 2010).
2. Phenotypic Diversity: Demonstrated that LH/ZI RXFP3+ cells are not a monolithic population but comprise distinct subtypes (GABAergic, glutamatergic, dopaminergic, PV+, SST+) that vary by anatomical location.
3. Methodological Validation: Validated the use of RNAscope multiplexing to resolve complex co-expression patterns (including triple-positive cells) that were previously difficult to characterize due to a lack of high-quality antibodies.
4. Functional Context: Linked specific RXFP3+ subpopulations to known functional circuits (e.g., A13 dopamine for motor/fear, PV+ for fear memory, SST+ for anxiety), providing a roadmap for future circuit-specific manipulations.

5. Significance and Implications

• Refining Defensive Behavior Models: The findings suggest that the diverse behavioral outputs of LH/ZI RXFP3 activation (ranging from freezing to escape jumping) may be driven by the activation of specific neurochemical subpopulations rather than a uniform response.
• Therapeutic Targeting: Understanding that RXFP3 is expressed on multiple neurotransmitter systems implies that relaxin-3 signaling acts as a global modulator of arousal and vigilance across diverse neural circuits, rather than targeting a single specific pathway.
• Paradigm Shift in ZI/LH Classification: The study argues against classifying these nuclei solely by a single marker (e.g., "GABAergic ZI"). Instead, it advocates for a multi-dimensional classification system (e.g., "GABAergic + RXFP3 + PV") to accurately delineate functional microcircuits.
• Future Directions: The identification of triple-positive cells (Rxfp3+/Gad1+/Slc17a6+) challenges the canonical view of excitatory/inhibitory segregation and warrants investigation into co-transmission mechanisms. Additionally, the study notes the limitation of using only male mice, suggesting future work should investigate potential sex differences in RXFP3 expression.